Compounds > phosphatidylcholines
Page last updated: 2024-09-05

phosphatidylcholines and ER-Negative PR-Negative HER2-Negative Breast Cancer

phosphatidylcholines has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (80.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Alijas, S; Bouzo, BL; de la Fuente, M; Díez-Villares, S; Gutiérrez-Lovera, C; Lores, S; Martínez-Val, J; Pensado-López, A; Sánchez, L; Saraiva, SM; Vázquez-Ríos, AJ1
Horikawa, M; Hosokawa, Y; Masaki, N; Matsushita, S; Ogura, H; Setou, M; Shiiya, N; Sugiyama, E; Takei, S1
Auguste, D; Guo, P; Liu, D; McCarthy, C; Tao, Y; Wang, B1
Burns, KE; Robinson, MK; Thévenin, D1
Jiang, T; Jiang, X; Pang, X; Pang, Z; Wan, X; Xu, W; Zhang, Q; Zhang, Z; Zhao, J; Zheng, X1

Other Studies

5 other study(ies) available for phosphatidylcholines and ER-Negative PR-Negative HER2-Negative Breast Cancer

ArticleYear
Edelfosine nanoemulsions inhibit tumor growth of triple negative breast cancer in zebrafish xenograft model.
    Scientific reports, 2021, 05-10, Volume: 11, Issue:1

    Topics: Administration, Cutaneous; Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Compounding; Emulsions; Excipients; Female; Humans; Nanoparticles; Permeability; Phosphatidylcholines; Phospholipid Ethers; Skin; Triglycerides; Triple Negative Breast Neoplasms; Xenograft Model Antitumor Assays; Zebrafish

2021
Recurrent triple-negative breast cancer (TNBC) tissues contain a higher amount of phosphatidylcholine (32:1) than non-recurrent TNBC tissues.
    PloS one, 2017, Volume: 12, Issue:8

    Topics: Adult; Aged; Aged, 80 and over; Female; Humans; Middle Aged; Phosphatidylcholines; Prognosis; Recurrence; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Triple Negative Breast Neoplasms

2017
Peptide density targets and impedes triple negative breast cancer metastasis.
    Nature communications, 2018, 07-04, Volume: 9, Issue:1

    Topics: Animals; Antineoplastic Agents; Binding, Competitive; Brain Neoplasms; Cell Line, Tumor; Cell Movement; Female; Gene Expression; Genes, Reporter; Humans; Liposomes; Liver Neoplasms; Luciferases; Lung Neoplasms; Membrane Microdomains; Mice; Mice, Nude; Peptides; Phosphatidylcholines; Phosphatidylethanolamines; Polyethylene Glycols; Protein Binding; Receptors, CXCR4; Triple Negative Breast Neoplasms; Xenograft Model Antitumor Assays

2018
Inhibition of cancer cell proliferation and breast tumor targeting of pHLIP-monomethyl auristatin E conjugates.
    Molecular pharmaceutics, 2015, Apr-06, Volume: 12, Issue:4

    Topics: Aminobenzoates; Animals; Cell Line, Tumor; Cell Membrane; Cell Proliferation; Chemistry, Pharmaceutical; Circular Dichroism; Drug Delivery Systems; Female; HeLa Cells; Humans; Hydrogen-Ion Concentration; Membrane Proteins; Mice; Neoplasm Transplantation; Oligopeptides; Peptides; Phosphatidylcholines; Spectrometry, Fluorescence; Triple Negative Breast Neoplasms; Tryptophan

2015
Lapatinib-loaded human serum albumin nanoparticles for the prevention and treatment of triple-negative breast cancer metastasis to the brain.
    Oncotarget, 2016, Jun-07, Volume: 7, Issue:23

    Topics: Administration, Intravenous; Animals; Antineoplastic Agents; Brain Neoplasms; Cell Adhesion; Cell Line, Tumor; Cell Movement; Drug Carriers; Drug Compounding; Drug Stability; Female; Lapatinib; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Neoplasm Invasiveness; Phosphatidylcholines; Protein Kinase Inhibitors; Quinazolines; Serum Albumin, Human; Tissue Distribution; Triple Negative Breast Neoplasms

2016